AdvisorShares Psychedelics ETF Rating $11.87 +0.34 (+2.95%) Closing price 05/2/2025 04:10 PM EasternExtended Trading$11.84 -0.03 (-0.25%) As of 05/2/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy 2.92Holdings in PSIL have an aggregate rating of Moderate Buy based on 98 analyst ratings issued in the past year covering 13 companies (68.3% of the portfolio).PSIL Aggregate Price Target$11.87High Prediction$11.87Average Prediction$11.87Low Prediction$11.87Holdings in PSIL have an aggregate price target of $11.87 and a range of $11.87 to $11.87 covering 13 companies (68.3% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy3 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 13 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.00%MNMDMind Medicine (MindMed)$6.93+5.2%2.5603 of 5 stars3.23$25.11 262.4%13Upcoming EarningsNews CoveragePositive NewsGap Up7.52%SAGESage Therapeutics$7.30-2.4%3.8667 of 5 stars2.00$8.81 20.7%19Earnings ReportAnalyst UpgradeAnalyst RevisionNews Coverage6.93%NRXPNRx Pharmaceuticals$2.05-1.4%2.1933 of 5 stars3.20$28.50 1,290.2%5Analyst ForecastNews Coverage6.91%ALKSAlkermes$31.78+3.9%4.1637 of 5 stars2.67$38.33 20.6%12Earnings ReportAnalyst ForecastNews Coverage6.65%STIMNeuronetics$4.58+2.7%0.9228 of 5 stars2.67$5.50 20.1%3Upcoming EarningsNews Coverage6.54%ATAIAtai Life Sciences$1.50+2.0%1.9024 of 5 stars3.00$10.50 600.0%3Gap Up5.39%CMPSCOMPASS Pathways$4.19+2.2%2.4298 of 5 stars3.00$20.20 382.1%6Upcoming EarningsNews CoveragePositive News4.80%VTGNVistagen Therapeutics$2.38+0.8%1.7867 of 5 stars4.001News CoveragePositive News4.52%NEUPNeuphoria Therapeutics Inc. - Common Stock$5.05+1.0%N/A3.00$21.00 315.8%14.42%GHRSGH Research$11.39+5.8%1.7497 of 5 stars3.00$30.86 170.9%7News Coverage4.21%NBIXNeurocrine Biosciences$109.68+2.9%4.8842 of 5 stars2.86$160.90 46.7%22Upcoming EarningsNews Coverage1.37%ENVBEnveric Biosciences$1.29+0.8%1.7162 of 5 stars3.00$10.00 675.2%1Gap Up1.03%RLMDRelmada Therapeutics$0.37+4.4%4.0638 of 5 stars2.00$4.25 1,064.1%5Upcoming Earnings This page (NYSEARCA:PSIL) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PSIL Stock Free PSIL Stock Alerts